European Medicines Agency's Human Medicines Committee Initiates Phased Review Of Revolution Medicines' Daraxonrasib To Treat Metastatic Pancreatic Cancer

Benzinga Newsdesk www.benzinga.com Neutral 94.1%

Neg 0% Neu 94.1% Pos 0%

https://www.ema.europa.eu/en/news/ema-fast-tracks-review-medicine-metastatic-pancreatic-cancer

Comments

No comments yet. Be the first!